Login Register Cart 0
Generic placeholder image

Current Pediatric Reviews

Editor-in-Chief

ISSN (Print): 1573-3963
ISSN (Online): 1875-6336

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
General Review Article

SARS-CoV-2 Encephalitis versus Influenza Encephalitis: More Similarities than Differences

Author(s): Kam L.E. Hon*, Alexander K.C. Leung, Yok W. Tan, Karen K.Y. Leung and Paul K.S. Chan

Volume 20, Issue 4, 2024

Published on: 20 September, 2023

Page: [525 - 531] Pages: 7

DOI: 10.2174/1573396320666230821110450

Price: $65

conference banner
Abstract

Background: From time to time, physicians face challenging diagnostic and therapeutic issues concerning the acute management of children with viral encephalitis.

Objectives: The aim of this article is to provide an updated narrative review on the similarities and differences between SARS-CoV-2 and influenza encephalitis.

Methods: A PubMed search was performed with the function “Clinical Queries” using the key terms “SARS-CoV-2” OR “Influenza” AND “Encephalitis”. The search strategy included metaanalyses, clinical trials, randomized controlled trials, reviews and observational studies. The search was restricted to the English literature and pediatric population. This article compares similarities and contrasts between SARS-CoV-2 and influenza-associated encephalitis.

Results: Encephalitis is an uncommon manifestation of both influenza and SARS-CoV-2. Both viruses are associated with fever and respiratory symptoms. However, SARS-CoV-2 patients may only have mild symptoms or be asymptomatic as silent carriers, rendering the disease spread difficult to control. Influenza patients usually have more severe symptomatology and are often bed bound for several days limiting its spread. Influenza is associated with seasonal and annual outbreaks, whereas SARS-CoV-2 has become endemic. Complications of encephalitis are rare in both viral infections but, when present, may carry serious morbidity and mortality. Many long-term sequelae of COVID- 19 infections (long COVID-19) have been described but not with influenza infections. Mortality associated with encephalitis appears higher with influenza than with SARS-CoV-2. Prophylaxis by immunization is available for both influenza and SARS-CoV-2. Specific efficacious antivirals are also available with oseltamivir for influenza and nirmatrelvir/ritonavir for SARS-CoV-2. Steroids are indicated with more severe SARS-CoV-2 but their role is not distinct in influenza disease.

Conclusion: Encephalitis is a rare complication of influenza and SARS-CoV-2 infections. Both carry significant morbidity and mortality. Efficacious vaccines for prophylaxis and antivirals for treatment are available for both viruses.

Keywords: Encephalitis, SARS-CoV-2, COVID-19, influenza, mortality, immunizations, long COVID syndrome, oseltamivir, nirmatrelvir/ritonavir.

« Previous Next »
[1]
Hon KL, Leung AKC, Leung KKY, Wong AHC. Impact of “long covid” on children: Global and Hong Kong perspectives. Curr Pediatr Rev 2022.
[http://dx.doi.org/10.2174/1573396319666221021154949] [PMID: 36281870]
[2]
Hon KL, Tan YW, Leung KKY, et al. Pediatric COVID-19 acute encephalopathy and mortality. Curr Pediatr Rev 2022.
[http://dx.doi.org/10.2174/1573396318666220617161606] [PMID: 35718976]
[3]
Hon KL. Successful treatment of influenza A encephalopathy. Hong Kong Med J 2020; 26(2): 154.
[http://dx.doi.org/10.12809/hkmj208417] [PMID: 32300080]
[4]
Yilmaz H. Investigation of respiratory tract coinfections in Coronavirus disease 2019 infected and suspected cases. North Clin Istanb 2022; 9: 421-8.
[http://dx.doi.org/10.14744/nci.2022.82608]
[5]
Pizzato Tondo L, Beck Paglioli Neto E, Arpini S, Passos G, Becker J. Encephalopathy due to COVID-19 with great response to glucocorticoids. Cureus 2021; 13(9): e17845.
[http://dx.doi.org/10.7759/cureus.17845] [PMID: 34660051]
[6]
Hon KL, Leung AKC, Leung WH, Leung KKY, Cheong KN, Lee PPW. Drugs for paediatric hyperinflammatory syndromes. Drugs Context 2022; 11: 1-11.
[http://dx.doi.org/10.7573/dic.2022-2-1] [PMID: 35720057]
[7]
Costa BK, Sato DK. Viral encephalitis: a practical review on diagnostic approach and treatment. J Pediatr (Rio J) 2020; 96(Suppl 1) (Suppl. 1): 12-9.
[http://dx.doi.org/10.1016/j.jped.2019.07.006] [PMID: 31513761]
[8]
Islam MA, Cavestro C, Alam SS, Kundu S, Kamal MA, Reza F. Encephalitis in patients with COVID-19: A systematic evidence-based analysis. Cells 2022; 11(16): 2575.
[http://dx.doi.org/10.3390/cells11162575] [PMID: 36010650]
[9]
Lin MC, Chi H, Chiu NC, Huang FY, Ho CS. Factors for poor prognosis of neonatal bacterial meningitis in a medical center in Northern Taiwan. J Microbiol Immunol Infect 2012; 45(6): 442-7.
[http://dx.doi.org/10.1016/j.jmii.2011.12.034] [PMID: 22571998]
[10]
Ku LC, Boggess KA, Cohen-Wolkowiez M. Bacterial meningitis in infants. Clin Perinatol 2015; 42(1): 29-45. vii-viii.
[http://dx.doi.org/10.1016/j.clp.2014.10.004] [PMID: 25677995]
[11]
Alamarat Z, Hasbun R. Management of acute bacterial meningitis in children. Infect Drug Resist 2020; 13: 4077-89.
[http://dx.doi.org/10.2147/IDR.S240162] [PMID: 33204125]
[12]
Ellul MA, Benjamin L, Singh B, et al. Neurological associations of COVID-19. Lancet Neurol 2020; 19(9): 767-83.
[http://dx.doi.org/10.1016/S1474-4422(20)30221-0] [PMID: 32622375]
[13]
Garg RK, Paliwal VK, Gupta A. Encephalopathy in patients with COVID‐19: A review. J Med Virol 2021; 93(1): 206-22.
[http://dx.doi.org/10.1002/jmv.26207] [PMID: 32558956]
[14]
Liotta EM, Batra A, Clark JR, et al. Frequent neurologic manifestations and encephalopathy‐associated morbidity in Covid‐19 patients. Ann Clin Transl Neurol 2020; 7(11): 2221-30.
[http://dx.doi.org/10.1002/acn3.51210] [PMID: 33016619]
[15]
Uginet M, Breville G, Assal F, et al. COVID‐19 encephalopathy: Clinical and neurobiological features. J Med Virol 2021; 93(7): 4374-81.
[http://dx.doi.org/10.1002/jmv.26973] [PMID: 33782993]
[16]
Britton PN, Dale RC, Blyth CC, et al. Influenza-associated encephalitis/encephalopathy identified by the australian childhood encephalitis study 2013-2015. Pediatr Infect Dis J 2017; 36(11): 1021-6.
[http://dx.doi.org/10.1097/INF.0000000000001650] [PMID: 28654561]
[17]
Surtees R, DeSousa C. Influenza virus associated encephalopathy. Arch Dis Child 2006; 91(6): 455-6.
[http://dx.doi.org/10.1136/adc.2005.092890] [PMID: 16714714]
[18]
Song X, Delaney M, Shah RK, Campos JM, Wessel DL, DeBiasi RL. Comparison of clinical features of COVID-19 vs. seasonal influenza A and B in US children. JAMA Netw Open 2020; 3(9): e2020495.
[http://dx.doi.org/10.1001/jamanetworkopen.2020.20495] [PMID: 32897374]
[19]
Wu Y, Kang L, Guo Z, Liu J, Liu M, Liang W. Incubation period of COVID-19 caused by unique SARS-CoV-2 strains. JAMA Netw Open 2022; 5(8): e2228008.
[http://dx.doi.org/10.1001/jamanetworkopen.2022.28008] [PMID: 35994285]
[20]
Pormohammad A, Ghorbani S, Khatami A, et al. Comparison of influenza type A and B with COVID‐19: A global systematic review and meta‐analysis on clinical, laboratory and radiographic findings. Rev Med Virol 2021; 31(3): e2179.
[http://dx.doi.org/10.1002/rmv.2179] [PMID: 33035373]
[21]
Hon KL, Leung KKY, Hui WF, Ng DKK. Applying lessons from influenza pandemics to the COVID‐19 pandemic. Pediatr Pulmonol 2021; 56(9): 3071-4.
[http://dx.doi.org/10.1002/ppul.25571] [PMID: 34288587]
[22]
Hon KL, Leung KKY. From influenza to COVID‐19 vaccinations: Counselling anxious parents about deaths following influenza immunizations in Korea. Pediatr Pulmonol 2021; 56(6): 1779-81.
[http://dx.doi.org/10.1002/ppul.25260] [PMID: 33765351]
[23]
Hoang A, Chorath K, Moreira A, et al. COVID-19 in 7780 pediatric patients: A systematic review. EClinicalMedicine 2020; 24: 100433.
[http://dx.doi.org/10.1016/j.eclinm.2020.100433] [PMID: 32766542]
[24]
Jeng MJ. Coronavirus disease 2019 in children: Current status. J Chin Med Assoc 2020; 83(6): 527-33.
[http://dx.doi.org/10.1097/JCMA.0000000000000323] [PMID: 32502117]
[25]
Choi SH, Kim HW, Kang JM, Kim DH, Cho EY. Epidemiology and clinical features of coronavirus disease 2019 in children. Clinical and Experimental Pediatrics 2020; 63(4): 125-32.
[http://dx.doi.org/10.3345/cep.2020.00535] [PMID: 32252139]
[26]
Ahmed M, Advani S, Moreira A, et al. Multisystem inflammatory syndrome in children: A systematic review. EClinicalMedicine 2020; 26: 100527.
[http://dx.doi.org/10.1016/j.eclinm.2020.100527] [PMID: 32923992]
[27]
Leung KKY, Hon KL, Wang MHT, Ng DDKK, Ip P. Paediatric multisystem inflammatory syndrome and COVID-19: another novel syndrome? Hong Kong Med J 2021; 27(2): 161-2.
[http://dx.doi.org/10.12809/hkmj208681]
[28]
Rajapakse N, Dixit D. Human and novel coronavirus infections in children: a review. Paediatr Int Child Health 2021; 41(1): 36-55.
[http://dx.doi.org/10.1080/20469047.2020.1781356] [PMID: 32584199]
[29]
Sharma C, Ganigara M, Galeotti C, et al. Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison. Nat Rev Rheumatol 2021; 17(12): 731-48.
[http://dx.doi.org/10.1038/s41584-021-00709-9] [PMID: 34716418]
[30]
COVID-19: The impact on pediatric emergency care. Pediatr Emerg Med Pract 2020; 17(Suppl 6-1): 1-27.
[31]
Rowley AH. Understanding SARS-CoV-2-related multisystem inflammatory syndrome in children. Nat Rev Immunol 2020; 20(8): 453-4.
[http://dx.doi.org/10.1038/s41577-020-0367-5] [PMID: 32546853]
[32]
Similarities and differences between flu and COVID-19. Available from: https://www.cdc.gov/flu/symptoms/flu-vs-covid19.htm
[33]
Duarte-Salles T, Vizcaya D, Pistillo A, Casajust P, Sena AG, Lai LYH. Baseline characteristics, management, and outcomes of 55,270 children and adolescents diagnosed with COVID-19 and 1,952,693 with influenza in France, Germany, Spain, South Korea and the United States: an international network cohort study. MedRxiv 2020.
[http://dx.doi.org/10.1101/2020.10.29.20222083]
[34]
Chua GT, Xiong X, Choi EH, et al. COVID-19 in children across three Asian cosmopolitan regions. Emerg Microbes Infect 2020; 9(1): 2588-96.
[http://dx.doi.org/10.1080/22221751.2020.1846462] [PMID: 33138739]
[35]
Shen K, Yang Y, Wang T, et al. Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts’ consensus statement. World J Pediatr 2020; 16(3): 223-31.
[http://dx.doi.org/10.1007/s12519-020-00343-7] [PMID: 32034659]
[36]
Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J. SARS-CoV-2 infection in children. N Engl J Med 2020; 382(17): 1663-5.
[http://dx.doi.org/10.1056/NEJMc2005073]
[37]
Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics 2020; 145(6): e20200702.
[http://dx.doi.org/10.1542/peds.2020-0702] [PMID: 32179660]
[38]
Zimmermann P, Curtis N. Coronavirus infections in children including COVID-19. Pediatr Infect Dis J 2020; 39(5): 355-68.
[http://dx.doi.org/10.1097/INF.0000000000002660] [PMID: 32310621]
[39]
Meningitis (bacterial) and meningococcal septicaemia in under 16s: recognition, diagnosis and management. NICE. 2015: Feb.ISBN-13: 978-1-4731-3040-1. https://www.ncbi.nlm.nih.gov/books/NBK555182/
[40]
Paul SP, Kini PK, Tibrewal SR, Heaton PA. NICE guideline review: fever in under 5s: assessment and initial management (NG143). Arch Dis Child Educ Pract Ed 2021; 107(3): edpract-2021-321718.
[http://dx.doi.org/10.1136/archdischild-2021-321718] [PMID: 34244233]
[41]
Berlit P, Bösel J, Gahn G, et al. “Neurological manifestations of COVID-19” - guideline of the German society of neurology. Neurological Research and Practice 2020; 2(1): 51.
[http://dx.doi.org/10.1186/s42466-020-00097-7] [PMID: 33283160]
[42]
Pilotto A, Masciocchi S, Volonghi I, et al. Clinical presentation and outcomes of severe acute respiratory syndrome coronavirus 2-related encephalitis: The ENCOVID multicenter study. J Infect Dis 2021; 223(1): 28-37.
[http://dx.doi.org/10.1093/infdis/jiaa609] [PMID: 32986824]
[43]
Lewis A, Frontera J, Placantonakis DG, et al. Cerebrospinal fluid in COVID-19: A systematic review of the literature. J Neurol Sci 2021; 421: 117316.
[http://dx.doi.org/10.1016/j.jns.2021.117316] [PMID: 33561753]
[44]
Mögling R, Fischer C, Stanoeva KR, et al. Sensitivity of detection and variant typing of SARS-CoV-2 in european laboratories. J Clin Microbiol 2022; 60(12): e01261-22.
[http://dx.doi.org/10.1128/jcm.01261-22] [PMID: 36445090]
[45]
Sanders PJLT, van Waardenburg DA, Vermeulen RJ. Influenza A-associated acute necrotising encephalopathy in a 10-year-old child. BMJ Case Rep 2020; 13(8): e233541.
[http://dx.doi.org/10.1136/bcr-2019-233541] [PMID: 32843445]
[46]
Wang GF, Li W, Li K. Acute encephalopathy and encephalitis caused by influenza virus infection. Curr Opin Neurol 2010; 23(3): 305-11.
[http://dx.doi.org/10.1097/WCO.0b013e328338f6c9] [PMID: 20455276]
[47]
Yen J, Al Moamen A, Margolesky J. Influenza B-associated encephalitis with rapid improvement with oseltamivir. Neurol Sci 2021; 42(2): 745-7.
[http://dx.doi.org/10.1007/s10072-020-04793-9] [PMID: 33047196]
[48]
Choi GJ, Park JY, Choi JS, et al. Influenza-associated neurologic complications in hospitalized pediatric patients. Pediatr Infect Dis J 2021; 40(12): e466-71.
[http://dx.doi.org/10.1097/INF.0000000000003332] [PMID: 34609108]
[49]
Hammond J, Leister-Tebbe H, Gardner A, et al. Oral nirmatrelvir for high-risk, nonhospitalized adults with covid-19. N Engl J Med 2022; 386(15): 1397-408.
[http://dx.doi.org/10.1056/NEJMoa2118542] [PMID: 35172054]
[50]
Pugin D, Vargas MI, Thieffry C, et al. COVID-19-related encephalopathy responsive to high-dose glucocorticoids. Neurology 2020; 95(12): 543-6.
[http://dx.doi.org/10.1212/WNL.0000000000010354] [PMID: 32680950]
[51]
Pilotto A, Odolini S, Masciocchi S, et al. Steroid‐responsive encephalitis in coronavirus disease 2019. Ann Neurol 2020; 88(2): 423-7.
[http://dx.doi.org/10.1002/ana.25783] [PMID: 32418288]
[52]
Qaseem A, Yost J, Miller MC, Andrews R, Jokela JA, Forciea MA. Outpatient treatment of confirmed COVID-19: Living, rapid practice points from the american college of physicians (version 1). Ann Intern Med 2023; 176: 115-24.
[http://dx.doi.org/10.7326/M21-3272] [PMID: 36442061]
[53]
Nakano A, Yamasaki R, Miyazaki S, Horiuchi N, Kunishige M, Mitsui T. Beneficial effect of steroid pulse therapy on acute viral encephalitis. Eur Neurol 2003; 50(4): 225-9.
[http://dx.doi.org/10.1159/000073864] [PMID: 14634267]
[54]
Howard A, Uyeki TM, Fergie J. Influenza-associated acute necrotizing encephalopathy in siblings. J Pediatric Infect Dis Soc 2018; 7(3): e172-7.
[http://dx.doi.org/10.1093/jpids/piy033] [PMID: 29741717]
[55]
Li XF, Ai B, Ye JW, et al. [Clinical analysis of seven cases of H1N1 influenza-associated encephalopathy in children]. Zhonghua Er Ke Za Zhi 2019; 57(7): 538-42.
[http://dx.doi.org/10.3760/CMA.J.ISSN.0578-1310.2019.07.009] [PMID: 31269554]
[56]
Takia L, Saini L, Keshavan S, et al. Neurological manifestations of influenza A (H1N1): Clinical features, intensive care needs, and outcome. Indian J Pediatr 2020; 87(10): 803-9.
[http://dx.doi.org/10.1007/s12098-020-03297-w] [PMID: 32358785]
[57]
Kim MG, Stein AA, Overby P, et al. Fatal cerebral edema in a child with COVID-19. Pediatr Neurol 2021; 114: 77-8.
[http://dx.doi.org/10.1016/j.pediatrneurol.2020.10.005] [PMID: 33246133]
[58]
Ninan S, Thompson P, Gershon T, Ford N, Mills W, Jewells V. Fatal pediatric COVID-19 case with seizures and fulminant cerebral edema. Child Neurol Open 2021; 8: 2329048X211022532.
[http://dx.doi.org/10.1177/2329048X211022532]
[59]
Hon KLE, Tsang YCK, Chan LCN, et al. Outcome of encephalitis in pediatric intensive care unit. Indian J Pediatr 2016; 83(10): 1098-103.
[http://dx.doi.org/10.1007/s12098-016-2068-4] [PMID: 27053179]
[60]
Au CC, Hon KL, Leung AKC, Torres AR. Childhood infectious encephalitis: An overview of clinical features, investigations, treatment, and recent patents. Recent Pat Inflamm Allergy Drug Discov 2021; 14(2): 156-65.
[http://dx.doi.org/10.2174/1872213X14999201124195724] [PMID: 33238854]
[61]
Rismanchi N, Gold JJ, Sattar S, et al. Neurological outcomes after presumed childhood encephalitis. Pediatr Neurol 2015; 53(3): 200-6.
[http://dx.doi.org/10.1016/j.pediatrneurol.2015.05.017] [PMID: 26220354]
[62]
Morishima T, Togashi T, Yokota S, et al. Encephalitis and encephalopathy associated with an influenza epidemic in Japan. Clin Infect Dis 2002; 35(5): 512-7.
[http://dx.doi.org/10.1086/341407] [PMID: 12173123]
[63]
Leung KKY, Hon KL. Lessons from animal culling during human pandemics: Is vaccination a viable option for animals? Curr Pediatr Rev 2023; 19(1): 2-4.
[http://dx.doi.org/10.2174/1573396318666220316124155] [PMID: 35297351]
[64]
Leung TF, Chan PK, Hon KL, Li AM. Surveillance of human- and swine-origin influenza in Hong Kong children. Hong Kong Med J 2018; 24(5) (Suppl. 6): 16-8.
[PMID: 30229730]
[65]
Hon KL, Leung KKY, Tang JW, Leung AKC, Li Y. COVID-19 in Hong Kong – Public health, food safety, and animal vectors perspectives. J Virol Methods 2021; 290: 114036.
[http://dx.doi.org/10.1016/j.jviromet.2020.114036] [PMID: 33285191]
[66]
Smith C, Odd D, Harwood R, et al. Deaths in children and young people in England after SARS-CoV-2 infection during the first pandemic year. Nat Med 2022; 28(1): 185-92.
[http://dx.doi.org/10.1038/s41591-021-01578-1] [PMID: 34764489]
[67]
LaRovere KL, Riggs BJ, Poussaint TY, et al. Neurologic involvement in children and adolescents hospitalized in the United States for COVID-19 or multisystem inflammatory syndrome. JAMA Neurol 2021; 78(5): 536-47.
[http://dx.doi.org/10.1001/jamaneurol.2021.0504] [PMID: 33666649]

Rights & Permissions Print Cite
Article Metrics
17
1
Wayfinder Image
© 2024 Bentham Science Publishers | Privacy Policy